| Phases of development | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | 1 and 2 years old (N = 57: 30 SCT, 27 TD) | 3 and 4 years old (N = 77: 35 SCT, 42 TD) | 5, 6, and 7 years old (N = 54: 28 SCT, 26 TD) | |||||||||||
AOI | SCT M (SD) | TD M (SD) | p-value | SCT M (SD) | TD M (SD) | p-value | Post hoc effect | Effect size (part. η2) | SCT M (SD) | TD M (SD) | p-value | Post hoc effect | Effect size (ηp 2) | |
Single face | Face | .52 (.17) | .57 (.21) | .132 | .45 (.16) | .54 (.16) | .009 | SCT < TD | .07 | .40 (.16) | .40 (.15) | .458 | Â | Â |
Eyes | .20 (.14) | .20 (.16) | .474 | .22 (.14) | .26 (.15) | .142 | Â | Â | .20 (.12) | .22 (.10) | .225 | Â | Â | |
Multiple faces | Faces | .56 (.15) | .60 (.21) | .172 | .53 (.14) | .57 (.18) | .124 | Â | Â | .43 (.18) | .52 (.17) | .029 | SCT < TD | .07 |
Eyes | .13 (.11) | .13 (.13) | .437 | .16 (.12) | .20 (.13) | .074 | Â | Â | .14 (.09) | .19 (.13) | .033 | SCT < TD | .06 |